METTL3-induced miR-222-3p upregulation inhibits STK4 and promotes the malignant behaviors of thyroid carcinoma cells
Journal of Clinical Endocrinology and Metabolism Sep 30, 2021
Lin S, Zhu Y, Ji C, et al. - Silencing METTL3 lowers miR-222-3p expression and consequently stimulates serine/threonine stress kinase 4 (STK4) expression, repressing thyroid carcinoma (TC) malignancy and metastasis.
The expression of METTL3 was higher in TC, which was associated with a poor prognosis for TC patients.
Increased METTL3 expression hastened the malignant behaviors of TC cells.
Mechanistically, METTL3 induced miR-222-3p expression by mediating the m6A modification of pri-miR-222-3p.
STK4 was targeted and inversely regulated by miR-222-3p.
METTL3 knockdown increased STK4 expression via downregulating miR-222-3p, decreasing TC cell malignancy as well as tumor growth and lung metastasis in nude mice.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries